3Fast-tracking regenerative medicine for traumatic brain injuryBrooke Bonsack，Matt Heyck，Chase Kingsbury，Blaise Cozene，Nadia Sadanandan，Jea-Young Lee，Cesar V. BorlonganREVIEWS1179-1190
4The N-formyl peptide receptors: contemporary roles in neuronal function and dysfunctionPeter J.G. Cussell，Margarita Gomez Escalada，Nathaniel G.N. Milton，Andrew W.J. PatersonREVIEWS1191-1198
5Adrenomedullin: an important participant in neurological diseasesFeng-Jiao Li，Si-Ru Zheng，Dong-Mei WangREVIEWS1199-1207
6Shifting equilibriums in Alzheimer's disease: the complex roles of microglia in neuroinflammation, neuronal survival and neurogenesisSophie C. Gray，Kerri J. Kinghorn，Nathaniel S. WoodlingREVIEWS1208-1219
7Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014-2019Bridget Martinez，Philip V. PeplowREVIEWS1220-1234
8ABC efflux transporters at blood-central nervous system barriers and their implications for treating spinal cord disordersLiam M. KoehnREVIEWS1235-1242
10Targeting the P2X7 receptor in microglial cells to prevent brain inflammationLin-Hua Jiang，Sébastien RogerPERSPECTIVES1245-1246
11Moderate/severe traumatic brain injury as a trigger of chronic neurodegeneration in humansSergio Bagnato，Cristina BoccagniPERSPECTIVES1247-1248
12Role of the NLRP3 inflammasome in neurodegenerative diseases and therapeutic implicationsYanhui Duan，Nathan Kelley，Yuan HePERSPECTIVES1249-1250
13Insights from human sleep research on neural mechanisms of Alzheimer's diseaseSusanna Cordone，Luigi De GennaroPERSPECTIVES1251-1252
14Diabetic retinopathy: a matter of retinal ganglion cell homeostasisElisabetta Catalani，Davide CerviaPERSPECTIVES1253-1254
15The new KV3.4 inhibitor BDS-I[1-8] as a potential pharmacological opportunity in Alzheimer's disease therapyIlaria Piccialli，Roselia Ciccone，Anna PannaccionePERSPECTIVES1255-1256
16Role of animal models in glaucoma researchAtsuko Kimura，Takahiko Noro，Takayuki HaradaPERSPECTIVES1257-1258
17Risk factors for corticosteroid insufficiency during the sub-acute phase of acute traumatic brain injuryXin Chen，Yan Chai，Shao-Bo Wang，Jia-Chong Wang，Shu-Yuan Yue，Rong-Cai Jiang，Jian-Ning ZhangBrain Injury and Neural Regeneration1259-1265
18Efficacy of cattle encephalon glycoside and ignotin in patients with acute cerebral infarction: a randomized, double-blind, parallel-group, placebo-controlled studyHui Zhang，Chuan-Ling Li，Feng Wan，Su-Juan Wang，Xiu-E Wei，Yan-Lei Hao，Hui-Lin Leng，Jia-Min Li，Zhong-Rui Yan，Bao-Jun Wang，Ren-Shi Xu，Ting-Min Yu，Li-Chun Zhou，Dong-Sheng FanBrain Injury and Neural Regeneration1266-1273
19MicroRNA-181c provides neuroprotection in an intracerebral hemorrhage modelXi Lu，Hui-Yuan Zhang，Zhi-Yi HeBrain Injury and Neural Regeneration1274-1282
20Target inhibition of caspase-8 alleviates brain damage after subarachnoid hemorrhageDa-Qiang Ke，Zhi-Yang Chen，Zhou-Ling Li，Xia Huang，Hui LiangBrain Injury and Neural Regeneration1283-1289
